Lifecore Biomedical share price logo

Lifecore Biomedical

NASDAQ: LFCR

$4.49

+0.03

(+0.67%)

as on

Lifecore Biomedical Stock Performance

as on September 22, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $4.21
    $4.51
    downward going graph

    6.24%

    Downside

    0.45%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.63
    $8.98
    downward going graph

    19.27%

    Downside

    100.00%

    Upside

    downward going graph

Lifecore Biomedical share price movements today

Previous Close
$4.46
Open
$4.39
Volume
437.7K
Market Cap
$168.8M
Day's Low - High
$4.21 - $4.51
52 Week Low - High
$3.63 - $8.98

Lifecore Biomedical Historical Returns

1 Month Return
-1.76 %
3 Month Return
-19.49 %
1 Year Return
-43.33 %
3 Year Return
-43.83 %
5 Year Return
0 %

Lifecore Biomedical Stock Fundamentals & Key Indicators

Check Lifecore Biomedical market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$168.8M

EPS (TTM)

-0.81

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.05

Industry PE ratio

-9.45

PEG Ratio

0.32573329628150105

EBITDA

3.0M

Revenue (TTM)

91.5M

Profit Margin

29.68%

Return On Equity TTM

-376.95%

Lifecore Biomedical Stock Valuation

Track how Lifecore Biomedical P/E has moved over time to understand its valuation trends.

Lifecore Biomedical in the last 5 years

  • Overview

  • Trends

Lowest (-8.89x)

December 31, 2025

Industry (-9.45x)

December 31, 2025

Today (-8.89x)

December 31, 2025

Highest (14.26x)

May 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -8.89x

Lifecore Biomedical vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lifecore Biomedical with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Lifecore Biomedical image
Lifecore Biomedical
StrongBuy$168.8MNA-4.0529.68%0.00%
United Therapeutics image
United Therapeutics
StrongBuy$21.2B148.77%16.3686.14%0.00%
Viatris image
Viatris
Buy$19.5B27.64%-47.0834.83%2.83%
Haleon PLC Sponsored ADR image
Haleon PLC Sponsored ADR
Buy$40.1BNA18.7765.57%1.34%
Zoetis image
Zoetis
Buy$29.5B-64.48%11.7570.87%2.93%
See all

Stock Returns calculator for Lifecore Biomedical Stock including INR - Dollar returns

The Lifecore Biomedical stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Lifecore Biomedical investment value today

Current value as on today

₹61,899

Returns

-₹38,101

(-38.1%)

Returns from Lifecore Biomedical Stock

-₹42,948 (-42.95%)

Dollar Impact

₹4,847 (+4.85%)

Analyst Recommendation on Lifecore Biomedical Stock

Based on 4 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 4 analysts, 75% of analysts recommend a 'BUY' rating for Lifecore Biomedical. Average target price of $6.75

Lifecore Biomedical Share Price Target

Get share price movements and forecasts by analysts on Lifecore Biomedical.

What analysts predicted

33.48%UPSIDE

Target Price

$6.75

Current Price

$4.49

Analyzed by

4 Analysts

Target

$6.75

Lifecore Biomedical target price $6.75, a slight upside of 33.48% compared to current price of $4.49. According to 4 analysts rating.

Indian Investors' Interest in Lifecore Biomedical Stock

Search interest for Lifecore Biomedical Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-11% versus previous 30 day period

Lifecore Biomedical Quarterly Profit & Loss

All numbers in Millions USD

Feb 2024
May 2024
Aug 2024
Nov 2024
Feb 2025
May 2025
Aug 2025
Dec 2025
Mar 2026
Dec 2026
Total Revenue
35
37
24
32
35
36
31
34
23
34
Gross Profit
11
17
5
11
9
13
7
12
4
12
Operating Income
0
2
-11
-1
-9
5
-3
2
-4
2
EBITDA
21
0
-8
0
-7
6
-7
4
-5
4
Interest Expense
4
5
5
5
5
5
6
7
7
7
Depreciation
2
2
1
2
2
1
1
2
2
2
Income Before Tax
15
-7
-16
-6
-14
-1
-9
-6
-14
-6
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
15
-7
-16
-6
-14
-1
-9
-6
-14
-6
Net Profit Margin
33.31%
45.59%
21.81%
34.04%
28.01%
38.37%
25.04%
35.34%
19.24%
35.34%

Lifecore Biomedical Annual Profit & Loss

All numbers in Millions USD

May 2017
May 2018
May 2019
May 2020
May 2021
May 2022
Aug 2023
May 2024
May 2025
Dec 2025
Total Revenue
532
524
557
160
100
111
103
128
128
129
Gross Profit
83
78
81
39
38
39
27
41
40
40
Operating Income
15
11
-8
-25
-8
-11
-21
-8
-17
-1
EBITDA
26
24
23
-7
0
12
-33
35
-8
8
Interest Expense
1
1
5
4
8
15
17
18
21
-2
Depreciation
10
11
14
18
19
18
13
8
8
9
Income Before Tax
15
16
3
-30
-29
-20
-63
9
-38
-30
Income Tax Expense
4
-9
1
-8
-6
-5
0
0
0
0
Net Income
10
24
2
-38
-32
-116
-99
12
-38
-30
Net Profit Margin
15.63%
14.94%
14.53%
24.61%
38.60%
35.11%
27.10%
32.63%
31.27%
31.37%

Lifecore Biomedical Quarterly Cash Flow

All numbers in Millions USD

Feb 2024
May 2024
Aug 2024
Nov 2024
Feb 2025
May 2025
Aug 2025
Dec 2025
Mar 2026
Dec 2026
Net Income
15
-7
-16
-6
-14
-1
-9
-6
-14
2
Operating Cash Flow
-1
8
0
-6
1
5
1
-2
4
0
Investing Cash Flow
-6
-2
-3
-2
1
-2
-1
9
-1
5
Financing Cash Flow
7
0
1
12
-6
0
-1
-3
0
-2
Change in Cash
0
5
-2
3
-4
2
-1
7
3
15

Lifecore Biomedical Annual Cash Flow

All numbers in Millions USD

May 2017
May 2018
May 2019
May 2020
May 2021
May 2022
Aug 2023
May 2024
May 2025
Dec 2025
Net Income
10
24
0
-15
-32
-116
-99
12
-38
-31
Operating Cash Flow
29
19
16
-17
16
-22
-17
0
0
12
Investing Cash Flow
-25
-35
-96
-23
-12
79
-4
-18
-6
-1
Financing Cash Flow
-8
13
79
40
-3
-57
39
7
6
-1
Change in Cash
-4
-2
-1
0
0
0
17
-10
0
0

Mutual Funds that own Lifecore Biomedical Stock

Check out the Mutual Funds with significant holdings in Lifecore Biomedical.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.326098%
1259030
Fidelity Concord Street Trust
0.982736%
371996
Fidelity Salem Street Trust
0.798801%
302371
VANGUARD SCOTTSDALE FUNDS
0.433608%
164134
SCHWAB CAPITAL TRUST
0.210823%
79803
See all

Global Institutional Holdings in Lifecore Biomedical

Funds
Holdings
Christopher Kiper
11.79%
Scott Miller
8.43%
Vanguard
3.83%
iShares
3.02%
Mario Gabelli
0.22%
See all

Insights on Lifecore Biomedical

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, LFCR stock has moved up by 4.9%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 23.19M → 34.16M (in $), with an average increase of 32.1% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -14.97M → -6.15M (in $), with an average increase of 143.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Viatris Inc. Common Stock has given 71.2% return, outperforming this stock by 114.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation Common Stock has given 74.9% return, outperforming this stock by 118.7%

About Lifecore Biomedical

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
OrganisationLifecore Biomedical
Headquarters3515 Lyman Boulevard, Chaska, MN, 55318, US
IndustryDrug Manufacturers - Specialty & Generic
CEOPaul Josephs
E-voting on sharesClick here to vote

Key Management of Lifecore Biomedical

Name

Title

Mr. Parker K. Javid

Vice President

Mr. Paul Josephs

President, CEO & Director

Mr. Ryan D. Lake CPA

Executive VP & CFO

Mr. Thomas D. Salus

Chief Legal & Administration Officer and Corporate Secretary

Mr. Thomas Guldager

Senior Vice President of Operations

Mr. Aaron Perlitsh

Director of Internal Audit & Chief Compliance Officer

Ms. Jackie Q. Klecker

Executive Vice President of Quality & Development Services

Mr. Mark DaFonseca

Chief Commercial Officer

FAQs

What is Lifecore Biomedical share price today?

Lifecore Biomedical share price today is $4.49 as on at the close of the market. Lifecore Biomedical share today touched a day high of $4.51 and a low of $4.21.

What is the 52 week high and 52 week low for Lifecore Biomedical share?

Lifecore Biomedical share touched a 52 week high of $8.98 on and a 52 week low of $3.63 on . Lifecore Biomedical stock price today i.e. is closed at $4.49,which is 50.00% down from its 52 week high and 23.86% up from its 52 week low.

What is Lifecore Biomedical's market capitalisation today?

Lifecore Biomedical market capitalisation is $0.00T as on .

How to invest in Lifecore Biomedical Stock (LFCR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Lifecore Biomedical on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lifecore Biomedical Shares that will get you 0.3341 shares as per Lifecore Biomedical share price of $4.49 per share as on September 22, 2026 at 1:29 am IST.

What is the minimum amount required to buy Lifecore Biomedical Stock (LFCR) from India?

Indian investors can start investing in Lifecore Biomedical (LFCR) shares with as little as ₹95.805 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.05 in Lifecore Biomedical stock (as per the Rupee-Dollar exchange rate as on ). Based on Lifecore Biomedical share’s latest price of $4.49 as on September 22, 2026 at 1:29 am IST, you will get 2.2272 shares of Lifecore Biomedical. Learn more about fractional shares .